Search

Your search keyword '"Soranzo ML"' showing total 75 results

Search Constraints

Start Over You searched for: Author "Soranzo ML" Remove constraint Author: "Soranzo ML"
Sorry, I don't understand your search. ×
75 results on '"Soranzo ML"'

Search Results

1. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART

2. Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects

Catalog

Books, media, physical & digital resources

3. Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction

4. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

5. Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis

6. Hospital-acquired infections in Italy: a region wide prevalence study

7. Evolution of HVR-1 Quasispecies after 1-Year Treatment in HIV/HCV-Coinfected Patients According to the Pattern of Response to Highly Active Antiretroviral Therapy

8. Open, Randomized, Multicentre Italian Trial on Peg-Ifn plus Ribavirin versus Peg-Ifn Monotherapy for Chronic Hepatitis C in HIV-Coinfected Patients on Haart

9. Response to Haart and Gb Virus Type C Coinfection in a Cohort of Antiretroviral-Naive HIV-Infected Individuals

10. The Management of Hepatitis B Virus/HIV-1 Co-Infected Patients Starting Their First Haart Regimen. Treating Two Infections for the Price of One Drug?

11. Variability in the Interpretation of Transmitted Genotypic HIV-1 Drug Resistance and Prediction of Virological Outcomes of the Initial Haart by Distinct Systems

12. Impact of Mutations Conferring Reduced Susceptibility to Lamivudine on the Response to Antiretroviral Therapy

13. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America

14. Outpatient parenteral antibiotic therapy in the elderly: an Italian observational multicenter study

15. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1 infected individuals with virological failure to all three antiretroviral-drug classes

16. Outpatient parenteral antibiotic therapy in the elderly: an Italian observational multicenter study.

17. Outpatient parenteral antibiotic therapy for bone and joint infections: an italian multicenter study.

18. Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from the Italian cohort of antiretroviral-naive patients study.

19. Hospital-acquired infections in Italy: a region wide prevalence study.

20. Comparison of once and twice daily dosing of didanosine in combination with stavudine for the treatment of HIV-1 infection. AI 454-146 Team.

22. Treatment of early chronic delta hepatitis with lymphoblastoid alpha interferon: a pilot study.

23. [Pharmacokinetics and clinical studies of a new cephalosporin: cefamandole nafate].

24. [Pneumococcal infections].

25. [Controlled clinico-statistical studies on the role of the nucleosides in an association of hepatoprotective and anti-asthenic action].

26. [Ceftriaxone, a long-acting cephalosporin. Microbiological, kinetic and clinical study].

27. [Cefotetan: microbiologic, kinetic and clinical aspects].

28. [Microbiological, kinetic and clinical study on a new cephamycin: cefotetan].

29. [Kinetic and clinical study of bacampicillin].

30. [Clinico-epidemiologic findings in a group of patients with acute viral hepatitis].

31. [Kinetic and clinical studies on a new cephalosporin: Cefotiam].

32. [Blood ammonia evaluation in acute hepatitis A and B].

33. [Brucellosis therapy].

34. Comparative trial of cephacetrile versus cephaloridine in the treatment of secondary respiratory infections in childhood pertussis.

35. [Piperacillin: microbiological and clinical studies].

36. [Pharmacokinetic and clinical research on a new antibiotic combination (amoxicillin and flucloxacillin in equivalent-weight dose)].

37. [Pharmacokinetic and clinical evaluation of cefoxitin].

38. [Clinico-epidemiologic study on 1258 cases of viral hepatitis admitted to Piedmont hospitals 1977-1979].

39. [Pharmacokinetics of intravenous rifampicin (RMP) and its clinical evaluation in purulent bacterial meningitis].

40. [Clinical study on a new cephalosporin: CGP 9000 (cefroxadine)].

41. [Josamycin, a new macrolide. Kinetic and clinical study].

42. [Antimicrobial therapy].

43. [Infection monitoring in orthopedics].

44. [Chronic hepatitis caused by B virus (HBV)].

45. [Cephalosporins and enzymuria].

46. [Pharmacokinetic and clinical research of a new phenyl ester of carbecinillin: carfecillin].

47. [Cefotiam, a new cephalosporin. Microbiological research, preliminary evaluation of its effect on phagocytosis and clinical multicenter research].

48. [Cefoperazone: microbiological, kinetic and clinical studies].

49. [Bacampicillin vs amoxicillin in respiratory pathology].